期刊文献+

大剂量输血患者去白细胞输血和常规输血的效果观察 被引量:4

Effect of leukocyte-depleted transfusion and routine transfusion on patients with massive blood tansfusion
原文传递
导出
摘要 目的 对比分析大剂量输血患者采用去白细胞输血和常规输血的临床效果.方法 350例需大剂量输血患者根据输血方式分成对照组(175例,常规输血)和研究组(175例,去白细胞输血).对比观察组间免疫功能及不良反应情况.结果 研究组输血前后细胞免疫和体液免疫指标比较差异未见统计学意义(P>0.05);对照组输血后CD4+及CD4+/CD8+明显下降,IgA、IgE、IgG及IgM均显著下降,且与研究组比较差异有统计学意义(P<0.05).研究组不良反应发生率(4.57%)低于对照组(18.86%),组间比较差异有统计学意义(P<0.05).结论 需大剂量输血患者使用去白细胞输血后的不良反应相对较少,且不会对其免疫功能造成严重不良影响. Objective To compare and analyze the effect of leukocyte-depleted transfusion and routine transfusion on patients with massive blood transfusion.Methods A total of 350 patients who needed massive blood transfusion were divided into control group (175 cases,routine blood transfusion)and study group (175 cases,leukocyte-depleted blood transfusion) according to the ways of blood transfusion.The immune function and adverse reactions between the two group were observed and compared.Results There was no significant difference in cellular immunity and humoral immunity indexes of study group before and after tansfusion (P 〉 0.05);in control group,CD4 + and CD4 +/CD8 + decreased significantly after tansfusion,and IgA,IgE,IgG and IgM all significantly decreased,the differences in the above indexes between study group and control group were significant (P 〈 0.05).Incidence of adverse reaction in study group (4.57%) was lower than that in control group (18.86%),and the difference was significant (P 〈 0.05).Conclusions Leukocyte-depleted transfusion has fewer adverse reactions for patients who need massive blood transfusion,and has no severe adverse effect on the immune function.
作者 张玉朝 Zhang Yuchao(Nanyang Blood Center, Nanyang 473000, Chin)
出处 《中国实用医刊》 2018年第3期93-95,共3页 Chinese Journal of Practical Medicine
关键词 大剂量输血 去白细胞输血 常规输血 不良反应 Massive blood transfusion Leukocyte-depleted transfusion Routine transfusion Adverse reaction
  • 相关文献

参考文献4

二级参考文献25

  • 1刘传喜,刘志芳,张辉,丁旭.去白细胞血液的临床应用效果观察[J].中国厂矿医学,2006,19(1):77-78. 被引量:6
  • 2林琼林.去白细胞全血和成分血的临床应用[J].江西医药,2006,41(6):412-413. 被引量:2
  • 3Beckman N, Sher G, Masse M, et al. BEST Working Party of the IS- BT. Review of the quality monitoring methods used by countries u- sing or implementing universal leukoreduction. Transfus Mod Rev, 2004,18( I ) :25-35.
  • 4Mtiller-Steinhardt M, Janetzko K, et al. Impact of various red cell concentrate preparation methods on the efficiency of prestoragc white cell filtration and an red cells during storage for 42 days. Transfusion, 1997,37 ( 11-12 ) : 1137-1142.
  • 5Standards for blood banks and transfusion services 26 edition 5. process control :24.
  • 6Guide to the preparation,use and quality assurance of blood compo- nents 16 edition Standards: ChapterS: Component mono-graphs: 253-257.
  • 7Bassuni WY, Blajehman MA, A1-Moshary MA. Why implement uni- versal leukoreduction? Hematol Oncol Stem Cell Ther, 2008, 1 (2) :106-123.
  • 8Gyongyossy-Issa MI, Weiss SL, Sowemimo-Coker SO, et al. Prestor- age leukoreduction and low-temperature filtration reduce hemolysis of stored red cell concentrates. Transfusion,2005,45 ( 1 ) :90-96.
  • 9Masse M. Universal leukoreduction of cellular and plasma compo- nents: process control and performance of the leukoreduction process. Transfus Clin Biol,2001,8(3) :297-302.
  • 10吴晓君,任俊泉.去白细胞输血对骨折术后感染的预防效果观察[J].山东医药,2007,47(33):96-96. 被引量:1

共引文献28

同被引文献34

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部